Form 8-K - Current report:
SEC Accession No. 0001493152-24-040955
Filing Date
2024-10-11
Accepted
2024-10-11 17:15:11
Documents
19
Period of Report
2024-10-08
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 58972
2 ex3-1.htm EX-3.1 3390
3 ex99-1.htm EX-99.1 21821
4 ex3-1_001.jpg GRAPHIC 868057
5 ex3-1_002.jpg GRAPHIC 682809
6 ex3-1_003.jpg GRAPHIC 1002109
7 ex3-1_004.jpg GRAPHIC 398352
  Complete submission text file 0001493152-24-040955.txt   4234639

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE mgrx-20241008.xsd EX-101.SCH 3033
9 XBRL LABEL FILE mgrx-20241008_lab.xml EX-101.LAB 34240
10 XBRL PRESENTATION FILE mgrx-20241008_pre.xml EX-101.PRE 24177
21 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4009
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 241368226
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)